Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and ...

Researchers at the University of Virginia believe they have discovered a key to understanding and potentially treating Alzheimer’s disease.

Alzheimer's disease affects millions of people around the world and occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and ...

Columbia scientists have found that boosting the performance of a self-cleansing system in the brain helps flush amyloid and tau toxins from the brains of mice and improves the animals' cognition.

Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.

Phil Robertson, patriarch of "Duck Dynasty," passed away at 79 due to Alzheimer's disease. Willie Robertson, Phil's son, shared that his father lost all memories in his final days.

Lemborexant, a sleep aid, may protect against tau buildup linked to Alzheimer's, offering new hope for neurodegenerative disease treatment.

A new pilot study reveals creatine monohydrate may boost brain energy and cognition in Alzheimer’s patients, signaling potential as a cost-effective, safe therapeutic strategy beyond the weight ...

Across 344,628 Alzheimer's case-control pairs, a history of HSV-1 diagnosis was present in 1,507 people (0.44%) with Alzheimer's disease and 823 matched controls (0.24%), reported Yunhao Liu, PhD ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. It’s got quite the name. The Lumipulse G pTau217 ...

More information: Almudena Chicote‐González et al, Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an ...